Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Partners IX Llc Canaan currently holds 3,589,554 shares of CytomX Therapeutics, Inc. (CTMX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Partners IX Llc Canaan has been a net seller of CTMX stock. They have purchased $0 and sold $3.3M worth of shares.
Partners IX Llc Canaan's most recent insider trade was on Oct 14, 2020, when they sold 400,000 shares at $0.00 per share.
Partners IX Llc Canaan serves as Executive at CytomX Therapeutics, Inc. (CTMX). They have executed 23 insider transactions totaling $3.3M over their tenure at the company.
Partners IX Llc Canaan holds the position of Executive at CytomX Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Partners IX Llc Canaan has shown a selling trading pattern, with $0 in total purchases and $3.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Partners IX Llc Canaan was on May 26, 2016, when they sold $416.0K worth of CTMX shares. This transaction involved 39,887 shares at $10.43 per share.
Partners IX Llc Canaan currently owns 3,589,554 shares of CytomX Therapeutics, Inc. (CTMX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Partners IX Llc Canaan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Partners IX Llc Canaan has 23 Form 4 filings on record as an insider at CytomX Therapeutics, Inc..
Set alerts for Partners IX Llc Canaan and 40,000+ other insiders.